Feedback

Strides Pharma Science Limited Announces Un-Audited Financial Results for Q2 2024

Bengaluru, July 29, 2024 — Strides Pharma Science Limited has announced the un-audited financial results for the quarter ending June 30, 2024. The results were reviewed and approved by the Board of Directors at their meeting held earlier today. This announcement is made in accordance with Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Highlights of the Announcement:

• Quarter Ended: June 30, 2024
• Type of Results: Un-audited Standalone and Consolidated Financial Results
• Board Meeting Timing: The meeting commenced at 11:40 hrs IST and concluded at 13:50 hrs IST.
• Statutory Auditor Report: The results are accompanied by the Limited Review Report of the Statutory Auditors.

Details of the Financial Results: The un-audited financial results reflect the company's performance for the quarter, providing insights into its financial health and operational efficiency. The detailed financial statements will be enclosed with the formal communication to the BSE Limited and the National Stock Exchange of India Limited.

Company Information:

• BSE Scrip Code: 532531
• NSE Scrip Code: STAR

Official Statement: "We are pleased to announce the un-audited financial results for the second quarter of 2024. The results reflect our ongoing commitment to maintaining transparency and upholding the trust of our stakeholders," said Manjula Ramamurthy, Company Secretary of Strides Pharma Science Limited.

The company also reiterated its adherence to regulatory compliance, ensuring that all disclosures are made in a timely and accurate manner. The financial results will provide investors and stakeholders with a clear view of the company's financial position and its future prospects.

Contact Information: